EVOTEC SE - ADR Share Price Today: Live Updates & Key Insights

EVOTEC SE - ADR share price today is $2.47, up -0.82%. The stock opened at $2.45 against the previous close of $2.45, with an intraday high of $2.48 and low of $2.405.

EVOTEC SE - ADR Share Price Chart

EVOTEC SE - ADR

us-stock
To Invest in {{usstockname}}
us-stock

EVOTEC SE - ADR Share Price Performance

$2.47 -0.0082(-0.82%) EVO at 23 Mar 2026 12:57 PM Drug Manufacturers - Specialty & Generic
Lowest Today 2.405
Highest Today 2.48
Today’s Open 2.45
Prev. Close 2.45
52 Week High 4.80
52 Week Low 2.31
Day’s Range: Low 2.405 High 2.48
52-Week Range: Low 2.31 High 4.80
1 day return -
1 Week return +1.23
1 month return -27.08
3 month return -18.33
6 month return -34.31
1 year return -32.32
3 year return -75.05
5 year return -88.87
10 year return -

EVOTEC SE - ADR Institutional Holdings

Mubadala Investment Company PJSC 1.29

Wellington Management Company LLP 0.51

BlackRock Inc 0.37

DCF Advisers, LLC 0.34

WCM Investment Management 0.16

ABC arbitrage SA 0.16

LVIP Wellington SMID Cap Value Std 0.15

VALIC Company I Mid Cap Value 0.11

Morgan Stanley - Brokerage Accounts 0.09

EQ/Mid Cap Value Managed Volatil IB 0.09

Mid Cap Value (Wellington) SP 0.07

Wellington Smid Opportunistic Value 0.07

Jane Street Group LLC 0.05

Pitcairn Co 0.05

Pitcairn Financial Group Inc 0.05

WCM Focused International Equity 0.04

WCM Focused International Equity ADR 0.04

Millennium Management LLC 0.03

LPL Financial Corp 0.03

QRG Capital Management, Inc. 0.02

Citadel Advisors Llc 0.02

Wellington CIF II SMID Opp Value S1 0.02

OLD MISSION CAPITAL LLC. 0.01

Optiver Holding B.V. 0.01

Lighthouse Investment Partners, LLC 0.01

Fore Capital, LLC 0.01

SNOWDEN CAPITAL ADVISORS LLC 0.01

HRT FINANCIAL LLC 0.01

Fidelity Nasdaq Composite Index 0.00

EVOTEC SE - ADR Market Status

Strong Buy: 1

Buy: 3

Hold: 1

Sell: 1

Strong Sell: 0

EVOTEC SE - ADR Fundamentals

Market Cap 870.54 M

PB Ratio 0.9375

PE Ratio 0.0

Enterprise Value 710.91 M

Total Assets 1912.50 M

Volume 95090

EVOTEC SE - ADR Company Financials

Annual Revenue FY24:781426000 781.4M, FY23:820802000 820.8M, FY22:751448000 751.4M, FY21:618034000 618.0M, FY20:500924000 500.9M

Annual Profit FY24:175051000 175.1M, FY23:219840000 219.8M, FY22:174065000 174.1M, FY21:151543000 151.5M, FY20:125743000 125.7M

Annual Net worth FY24:-83913000 -83.9M, FY23:-94983000 -95.0M, FY22:-175655000 -175.7M, FY21:215510000 215.5M, FY20:6252000 6.3M

Quarterly Revenue Q3/2025:163887000 163.9M, Q2/2025:171235000 171.2M, Q1/2025:199978000 200.0M, Q3/2024:184890000 184.9M, Q2/2024:182123000 182.1M

Quarterly Profit Q3/2025:-62000 -0.1M, Q2/2025:8594000 8.6M, Q1/2025:27226000 27.2M, Q3/2024:18283000 18.3M, Q2/2024:15741000 15.7M

Quarterly Net worth Q3/2025:-43087000 -43.1M, Q2/2025:-43478000 -43.5M, Q1/2025:-31577000 -31.6M, Q3/2024:-39634000 -39.6M, Q2/2024:-94932000 -94.9M

About EVOTEC SE - ADR & investment objective

Company Information Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just " Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic disease, and rare diseases; central nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. It has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. The company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Organisation Drug Manufacturers - Specialty & Generic

Employees 4788

Industry Drug Manufacturers - Specialty & Generic

CEO Dr. Christian Wojczewski Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

EVOTEC SE - ADR FAQs

What is the share price of EVOTEC SE - ADR today?

The current share price of EVOTEC SE - ADR is $2.47.

Can I buy EVOTEC SE - ADR shares in India?

Yes, Indian investors can buy EVOTEC SE - ADR shares by opening an international trading and demat account with Motilal Oswal.

How to buy EVOTEC SE - ADR shares in India?

You can easily invest in EVOTEC SE - ADR shares from India by:

Can I buy fractional shares of EVOTEC SE - ADR?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of EVOTEC SE - ADR?

EVOTEC SE - ADR has a market cap of $870.54 M.

In which sector does EVOTEC SE - ADR belong?

EVOTEC SE - ADR operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in EVOTEC SE - ADR stocks?

To invest, you typically need:

What is the PE and PB ratio of EVOTEC SE - ADR?

The PE ratio of EVOTEC SE - ADR is N/A and the PB ratio is 0.94.